Navigation Links
New Blood Clot Removal System Successfully Restores Blood Flow
Date:7/25/2013

PARK CITY, Utah, July 25, 2013 /PRNewswire-iReach/ -- Dr. Nick Cavros, interventional cardiologist with Cardiovascular Institute of the South (CIS) at Lafayette General Medical Center in Lafayette, Louisiana, used a new hand-held mechanical aspiration system to remove blood clots and increase blood flow.

(Photo: http://photos.prnewswire.com/prnh/20130725/MN53083)

The patented ASPIRE Aspirator connects to any aspiration catheter and aspirates, or sucks out, blood clots in blocked arteries and veins.  ASPIRE systems allow clinicians to instantly start, stop, increase, decrease, or pulse aspiration during a variety of procedures. 

During the procedure, which takes place in a catheterization laboratory, a small catheter is inserted into the patient's leg and is guided to the blocked vessel.  Once a catheter is in the vein or artery, the cardiologist can diagnose the location and extent of the lesion.  Treatment options vary depending on the age, size, and location of the blood clot.  Clinicians may follow blood clot aspiration with stent, bypass, or other intervention. 

"Most people know that blood clots are lethal in the heart and brain.  But, blood clots can be life-threatening in the legs, lung, and other organs too," said Dr. Cavros.  "Our CIS team has experience treating a wide range of blood clots with numerous tools.  We focus on the patient's needs and tailor the right therapy to improve care—fast."

Blood clot aspiration is typically performed with basic syringes or electromechanical pumps.  Basic syringes require two hands to operate, are volume limited, and do not maintain consistent aspiration force.  Electromechanical systems can aspirate more volume with increased force, but are expensive, can be difficult to use, require extensive set-up, and do not give the clinician tactile feedback during aspiration. 

"Speed and accuracy is important to remove blood clots and restore blood flow," continued Dr. Cavros.  "The ASPIRE system improves aspiration speed and performance, and it allows us to use a variety of catheters specific to the patient's needs." 

"We are pleased that our technology was used again to improve patient care," said Shawn Fojtik, CEO of Control Medical Technology.  "Improving aspiration can improve care.  The ASPIRE Aspirator meets this challenge with a simple technology to improve aspiration speed and control."       

CIS is one of the most respected groups of cardiologists, representing nearly every specialty in heart and circulatory medicine.  With a team of nearly 500 dedicated team members, CIS serves communities throughout Louisiana, as well as national and international patients, at its 14 clinics.  CIS consistently positions itself at the forefront of technology by providing the most up-to-date technology coupled with compassionate care.  This mission has guided the institute for nearly 30 years of service to south Louisiana.  For more information about CIS, call 1-800-425-2565 or visit www.cardio.com

Control Medical Technology designs, develops, and markets innovative blood clot (thrombus) management, biopsy, and aspiration devices, including the patented ASPIRE Thrombus Aspirator, patented ASPIRE MAX Thrombus Aspiration Catheter Systems, and other devices to improve patient care.  For more information about Control Medical, call 1-954-9345 or visit www.aspirationmedical.com

Cardiovascular Institute of the South Media contact:

Anne Kolwe, Marketing Director

Phone: (985) 872-5980

Fax: (985) 851-0780

anne.kolwe@cardio.com

www.cardio.com

 

Control Medical Media contact: 

Carolina Vance

(954) 457-2450

info@ASPIRATIONMEDICAL.com

www.ASPIRATIONMEDICAL.com

Media Contact: Shawn Fojtik, Control Medical Technology, 4356029640, fojtik@Post.harvard.edu

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Control Medical Technology
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
2. SynGen Inc. Receives FDA 510K Clearance to Market SynGenX-1000 Cord Blood Processing Platform
3. Global Blood Pressure Monitor Market 2012-2016: High Competition among Vendors Could Pose a Challenge to Growth of this Market
4. Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211
5. Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
6. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
7. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
8. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
9. Celebrating 25 Years and Counting: Leukemia and Lymphoma Societys "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients
10. "Blood Therapy" Has Patients Flocking to Washington DCs Pioneering Pain Doctor
11. Inostics Blood-based Mutation Testing Receives CLIA Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 2017  Bayer has awarded grants totaling more than $2 ... its prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians ... and Uniformed Services University of the Health Sciences ... Grant recipients were announced last night during a reception at ... Berlin, Germany . ...
(Date:7/10/2017)... medical equipment and supply demand is forecast to reach ... Equipment & Supplies: United States , a report ... demand for medical services – driven in large part ... gains in disposable personal income – will boost sales ... also drive sales as providers and patients seek the ...
(Date:7/6/2017)... ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, is ... nutrition support. To celebrate its anniversary, ThriveRx recently launched a ... new look with improved organization to create the best user experience for ... ... "We,ve made several great strides ...
Breaking Medicine Technology:
(Date:7/20/2017)... Houston, Texas (PRWEB) , ... July 20, 2017 ... ... and litigation law firm headquartered in Houston, is pleased to announce their expansion ... decades of affordable housing experience, directors Alysse Hollis and Ronald Bell, and of ...
(Date:7/20/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of ... up with a Microsoft Corp. employee-led hackathon team for the 2017 Microsoft One Week ... Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every person and every ...
(Date:7/20/2017)... ... 20, 2017 , ... Girl Up Campaign Director, Melissa Kilby, ... in support of providing girls access to education in refugee settings. In May, Congressman ... Girls’ Access to Education in Vulnerable Settings Act.” Yesterday, companion legislation was introduced ...
(Date:7/20/2017)... Lake, Wisconsin (PRWEB) , ... July 20, 2017 ... ... release of two products that further expand its existing adherence automation lines. The ... solutions that mirror the advanced technology of TCG’s standard products, but at a ...
(Date:7/20/2017)... ... July 20, 2017 , ... With ... 2014, top travel insurance solution company VisitorsCoverage Inc. has launched TMQuotes, a new ... international travel insurance products online, under their own brand. The online marketplace bridges ...
Breaking Medicine News(10 mins):